NCT Number: NCT01981603
Transplant Navigator Dissemination
Primary Aim A. To disseminate and determine the impact of streamlined navigation on wait listing and number of transplants. The navigator will provide tailored information and assistance to help dialysis patients complete the tasks required at each step in the transplant process. In the control group, dialysis patients will continue to get usual care from their nephrologists and dialysis facility personnel.
Hypothesis: Compared to control patients, intervention patients will be significantly more likely to be wait listed or receive a kidney transplant.
Looking for future studies?
Notify MeKey information
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Lutheran Hospital, Fort Wayne, Indiana, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- between the ages of 18-70
- receiving in center hemodialysis
Exclusion criteria
- less than 18 years of age
- older than 70 years of age
Treatment and study plan
Primary outcomes
-
The proportion of patients who are wait listed or receive a kidney transplant.
Time frame: approximately 3 years
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Catherine Sullivan
Other
Registry information
Important dates
- Study start
- 2014
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Nov 11, 2013
- Registry last updated
- Mar 22, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
NCT01289717
Fibrosis, Kidney Transplant
Phoenix, Arizona, United States
View Trial DetailsTreg Therapy in Subclinical Inflammation in Kidney Transplantation
NCT02711826
Adult Living Donor Kidney Transplant Recipients, Kidney Transplant
Birmingham, Alabama, United States
View Trial DetailsEffects of Inhibiting Early Inflammation in Kidney Transplant Patients
NCT02495077
Kidney Transplant
Birmingham, Alabama, United States
View Trial DetailsRituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
NCT00307125
Graft Function/Survival, Kidney Transplant
Birmingham, Alabama, United States
View Trial Details